Morning session |
Welcome
Karl Mahler, Head of Investor Relations
|
PDF
|
|
Pharma strategy, Portfolio planning, Productivity and new technologies
Bill Anderson, CEO Roche Pharmaceuticals
|
PDF
|
|
Market opportunities; Pricing & Access
Teresa Graham, Head Global Product Strategy
|
PDF
|
|
Oncology franchise
Sandra Horning, Chief Medical Officer and Head Global Product Development
|
PDF
|
|
Neuroscience franchise
Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
|
PDF
|
|
Afternoon sessions (breakouts) |
Immunology & Infectious diseases
Cristin Hubbard, Senior Vice President, Global Product Strategy, Immunology,
Infections
Diseases and Ophthalmology
Zafar Hakim, Senior Director, Disease Area Strategy Immunology, Infectious Diseases
&
Ophthalmology, Global Product Strategy
|
PDF
|
mp3
|
Late stage pipeline Ophtamology
Atul Dandekar Ophthalmology Franchise Head in Global Product Strategy
Sascha Fauser, Head of Ophthalmology group (Discovery and Translational
Medicine)
|
PDF
|
mp3
|
Digitalisation & Personalized healthcare
Bryn Roberts Global Head of Operations & Informatics for Pharma Research and
Early
Development
|
PDF
|
mp3
|
Appendix |
Pipeline overview |
PDF
|
|
Patient populations |
PDF
|
|